BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 32071666)

  • 21. Reductions in bilateral transverse sinus pressure gradients with unilateral transverse venous sinus stenting for idiopathic intracranial hypertension.
    Larson A; Rinaldo L; Chen JJ; Cutsforth-Gregory J; Theiler AR; Brinjikji W
    J Neurointerv Surg; 2021 Feb; 13(2):187-190. PubMed ID: 32482835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature.
    Puffer RC; Mustafa W; Lanzino G
    J Neurointerv Surg; 2013 Sep; 5(5):483-6. PubMed ID: 22863980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Body Mass Index on Venous Sinus Pressures in Idiopathic Intracranial Hypertension Patients Before and After Endovascular Stenting.
    Raper DMS; Ding D; Buell TJ; Crowley RW; Starke RM; Liu KC
    Neurosurgery; 2018 Apr; 82(4):555-561. PubMed ID: 28431144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual and neurological outcomes following endovascular stenting for pseudotumor cerebri associated with transverse sinus stenosis.
    Radvany MG; Solomon D; Nijjar S; Subramanian PS; Miller NR; Rigamonti D; Blitz A; Gailloud P; Moghekar A
    J Neuroophthalmol; 2013 Jun; 33(2):117-22. PubMed ID: 23502837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous sinus stenting in patients without idiopathic intracranial hypertension.
    Levitt MR; Albuquerque FC; Gross BA; Moon K; Jadhav AP; Ducruet AF; Crowley RW
    J Neurointerv Surg; 2017 May; 9(5):512-515. PubMed ID: 27199383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions.
    Ahmed RM; Wilkinson M; Parker GD; Thurtell MJ; Macdonald J; McCluskey PJ; Allan R; Dunne V; Hanlon M; Owler BK; Halmagyi GM
    AJNR Am J Neuroradiol; 2011 Sep; 32(8):1408-14. PubMed ID: 21799038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term efficacy of venous sinus stenting in the treatment of idiopathic intracranial hypertension.
    Cheng H; Jin H; Hu Y; Chen L; Chen Z; Zhong G
    CNS Neurosci Ther; 2024 Jan; 30(1):e14356. PubMed ID: 37469247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Men Are from Mars, Idiopathic Intracranial Hypertension Is from Venous: The Role of Venous Sinus Stenosis and Stenting in Idiopathic Intracranial Hypertension.
    Dinkin M; Oliveira C
    Semin Neurol; 2019 Dec; 39(6):692-703. PubMed ID: 31847040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endovascular stenting for idiopathic intracranial hypertension with different types of venous sinus stenosis].
    Su H; Zhang RJ; Cao XY; Liu XF; Du ZH; Li BM; Wang J
    Zhonghua Nei Ke Za Zhi; 2021 Aug; 60(8):728-733. PubMed ID: 34304448
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuro-ophthalmological evaluation including optical coherence tomography surrounding venous sinus stenting in idiopathic intracranial hypertension with papilledema: a case series.
    Hendrix P; Whiting CJ; Griessenauer CJ; Bohan C; Schirmer CM; Goren O
    Neurosurg Rev; 2022 Jun; 45(3):2239-2247. PubMed ID: 35067804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fifty shades of gradients: does the pressure gradient in venous sinus stenting for idiopathic intracranial hypertension matter? A systematic review.
    McDougall CM; Ban VS; Beecher J; Pride L; Welch BG
    J Neurosurg; 2018 Mar; 130(3):999-1005. PubMed ID: 29498569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined surgical repair and venous sinus stenting for patients with skull base encephaloceles secondary to dural venous sinus stenosis.
    Tosi U; Ramos A; Rampichini M; Alexiades G; Boddu S; Cisse B; Kacker A; Patsalides A; Tabaee A; Schwarz J; Schwartz TH; Ramakrishna R
    Acta Neurochir (Wien); 2023 Aug; 165(8):2283-2292. PubMed ID: 37344735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary balloon angioplasty of venous Sinus stenosis in idiopathic intracranial hypertension.
    Carlos Martinez-Gutierrez J; Kole MJ; Lopez-Rivera V; Inam ME; Tang R; Al-Zubidi N; Adesina OO; Lekka E; Engstrom AC; Sheth S; Pedroza C; Day AL; Chen PR
    Interv Neuroradiol; 2023 Aug; 29(4):358-362. PubMed ID: 35323053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous sinus stenting shortens the duration of medical therapy for increased intracranial pressure secondary to venous sinus stenosis.
    Shazly TA; Jadhav AP; Aghaebrahim A; Ducruet AF; Jankowitz BT; Jovin TG; Bonhomme GR
    J Neurointerv Surg; 2018 Mar; 10(3):310-314. PubMed ID: 28487359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Resistivity Index Analysis in the Prediction of Hemodynamically Significant Venous Sinus Stenosis in Patient With Idiopathic Intracranial Hypertension.
    Mohammaden MH; Husain MR; Brunozzi D; Hussein AE; Atwal G; Charbel FT; Alaraj A
    Neurosurgery; 2020 May; 86(5):631-636. PubMed ID: 31384935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergent cerebral venous stenting: A valid treatment option for fulminant idiopathic intracranial hypertension.
    Horev A; Ben-Arie G; Walter E; Tsumi E; Regev T; Aloni E; Biederko R; Zlotnik Y; Lebowitz Z; Shelef I; Honig A
    J Neurol Sci; 2023 Sep; 452():120761. PubMed ID: 37572407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic intracranial hypertension: 120-day clinical, radiological, and manometric outcomes after stent insertion into the dural venous sinus.
    Asif H; Craven CL; Siddiqui AH; Shah SN; Matloob SA; Thorne L; Robertson F; Watkins LD; Toma AK
    J Neurosurg; 2018 Sep; 129(3):723-731. PubMed ID: 28984521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Case of a Patient with Idiopathic Intracranial Hypertension Who Required Additional Stenting for Stent-Adjacent Stenosis.
    Uesugi S; Karukaya T; Nakayama H
    J Neuroendovasc Ther; 2022; 16(4):211-217. PubMed ID: 37502447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of dural venous sinus stenting in treating idiopathic intracranial hypertension with acute vision loss.
    Zehri AH; Lee KE; Kartchner J; Arnel M; Martin T; Wolfe SQ; Fargen KM
    Neuroradiol J; 2022 Feb; 35(1):86-93. PubMed ID: 34224285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transverse venous sinus stenting for idiopathic intracranial hypertension: Safety and feasibility.
    Koovor JM; Lopez GV; Riley K; Tejada J
    Neuroradiol J; 2018 Oct; 31(5):513-517. PubMed ID: 29882475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.